Corrigendum: Correction of Acknowledgments. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma

Article information

Endocrinol Metab. 2022;37(1):180-180

Publication date (electronic) : 2022 February 28

doi : https://doi.org/10.3803/EnM.2022.103

Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Won Bae Kim

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Corresponding author: Won Bae Kim. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea, Tel: +82-2-3010-3913, Fax: +82-2-3010-6962, E-mail: kimwb@amc.seoul.kr

Endocrinol Metab 2021;36:717-724

https://doi.org/10.3803/EnM.2021.1042

This corrects the article “Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma” in Volume 36 on page 717.

There was an error in our recently published article in the Acknowledgments section, which should be revised as follows.

Acknowledgements

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC19C0215).

We would like to apologize for any inconvenience or misunderstanding.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.